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Percutaneous treatment with carbon dioxide (CO2) mist, CO2 gas dissolved in water, contributes to
improved cardiac function after myocardial infarction (MI). In this study, we investigated the effects of
repeated pretreatment with CO2 mist on cardiac dysfunction after MI. The CO2 mist was generated by a
dry mist production unit. The whole body of rats below the axilla was wrapped in a polyethylene bag,
which was sealed and ﬁlled with the CO2 mist in the draft cabinet for 30 min daily for 7 days. MI was
induced by ligation of the coronary artery in untreated (UT), CO2 gas-pretreated (CG), and CO2 mist-
pretreated (CM) rats. The infarct size and the increase in oxidative stress due to MI were signiﬁcantly
smaller in the CM rats than in the UT rats. Furthermore, the expression of inﬂammation-related genes,
such as monocyte chemoattractant protein-1, and ﬁbrosis-related genes, such as transforming growth
factor-b1, was signiﬁcantly suppressed in the CM rats. The CM rats had a better left ventricular ejection
fraction than the UT rats 7 days after MI. These parameters in the CG rats were the same as in the UT
group. Thus, CO2 mist preparative treatment may be potentially useful for the reduction of MI.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
The cardioprotective effect of ischemic preconditioning was
reported in 1986 (1). Ischemic preconditioning resulted in infarct
sizes that were approximately 25% of those observed in untreated
hearts. The original study not only demonstrated the car-
dioprotection from ischemia/reperfusion (I/R) injury, but also pro-
vided a model with which to study ways to protect the ischemic
heart. There have been many subsequent reports of the car-
dioprotective effects of remote ischemic preconditioning (2e4), in
which brief and repeated non-lethal ischemia and reperfusion of alogy, Osaka City University
545-8585, Japan. Tel.: þ81 6
. Izumi).
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).remote organ or tissue can increase the heart's tolerance of acute IR
injury.
Balneotherapy in hot springs containing a high concentration of
carbon dioxide (CO2) has long been applied clinically to treat a
variety of diseases. The effect of CO2-enriched water on the cuta-
neous circulation depends primarily on the vasodilatation effects
elicited by the CO2 that diffuses into the subcutaneous tissue
through the skin layers (5,6). Previous studies have reported that
CO2-enriched water induces peripheral vasodilatation, which in-
creases cutaneous blood ﬂow (6e8). Thus, bathing in CO2-enriched
water may be a useful therapeutic method for patients with car-
diovascular diseases. However, no artiﬁcial CO2-enriched water
bathing system is widely available, probably because of the high
setup cost and the difﬁculty of maintaining a constant artiﬁcial CO2
concentration.
Recently, instead of a CO2 bathing system, a new and simple
device was developed to generate CO2 mist, i.e., water containing anese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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reported that percutaneous treatment with CO2 mist produced by
this device improved the development of cardiac remodeling after
myocardial infarction (MI) (9). Treatment with CO2 mist also
accelerated angiogenesis in a mouse model of peripheral arterial
disease (10). However, it is still unclear whether pretreatment with
CO2 mist has a cardioprotective effect against myocardial ischemic
injury. In the present study, we investigated whether pretreatment
with CO2 mist can reduce the infarct size in an experimental animal
model of MI.
2. Materials and methods
2.1. Animals and experimental design
All procedures were performed in accordance with Osaka City
University animal care guidelines, which conform to the Guide for
the Care and Use of Laboratory Animals published by the US Na-
tional Institutes of Health (NIH Publication No. 85e23, revised
1996). The 8-week-old male Wistar rats weighing 260e290 g were
purchased from CLEA Japan, Inc (Osaka).
The principal aim of the present study was to determine
whether repeated pretreatment with CO2 mist can attenuate car-
diac dysfunction after MI. After 24 h of the last treatment, MI was
induced by permanent ligation of the left coronary artery (9,11,12)
in rats that were either untreated (UT), or had undergone pre-
treatment with CO2 gas (CG) or CO2 mist (CM) daily for 7 days.
Untreated and sham-operated rats were used as a control (CON)
group. Forty-eight hours after MI induction, the infarct size was
quantiﬁed by the Evans blue method (13). Three days after MI in-
duction, the blood pressure and heart rate of the conscious rats
were measured by the tail-cuff method (BP98A; Softron, Tokyo); a
blood sample was then collected and the heart weight was
measured. Seven days after MI induction, a transthoracic echocar-
diographic study was performed, and the rats were then sacriﬁced.
The ventricle was separated into the upper and lower portions, and
then the upper portion of the left ventricle was divided into the
marginal and non-infarcted zones. The specimens obtained were
immediately frozen in liquid nitrogen and stored at 80 C until
use. The lower portion of the left ventricle was ﬁxed in 10% form-
aldehyde overnight and embedded in parafﬁn.
2.2. CO2 gas or CO2 mist treatment procedure
The CO2 mist was generated by a dry mist production unit (ACP
JAPAN Co., Ltd., Tokyo) (9,10). In brief, 100% concentrated CO2 was
compounded and compressed with water through dual ﬂuid noz-
zles at 4 atm. The rat was placed on a heating plate at 37 C, under
anesthesia with sodium pentobarbital (40 mg kg1, ip), and the
whole body below the axilla was encased in a sealed polyethylene
bag. The bag was then ﬁlled with CO2 mist or CO2 gas in the draft
cabinet (9,10). The UT/MI and CON rats were kept on a heating plate
at 37 C for 30 min once a day under anesthesia.
2.3. Echocardiographic study
Transthoracic echocardiography was performed using a Xario
ultrasound device (Toshiba Medical Systems, Tokyo) with a 6-MHz
cardiac transducer, according to previously described methods
(12,14). In brief, rats were anesthetized with pentobarbital. A two-
dimensional short-axis view of the left ventricle was obtained at
the level of the papillary muscles. The left ventricular (LV) ejection
fraction (LVEF) was calculated by measuring the LV end-diastolic
volume (LVEDV) and the LV end-systolic volume (LVESV), by us-
ing a modiﬁed Simpson's method. Pulsed wave Doppler spectra(early rapid ﬁlling [E] wave and atrial contraction [A] wave) of
mitral inﬂow velocities were recorded from the apical 4-chamber
view, with the sample volume placed near the tips of the mitral
leaﬂets and adjusted to the position at which velocity was
maximum and the ﬂowpatternwas laminar, and the ratio of E wave
velocity to A wave velocity (E/A) was calculated.
2.4. Histology and evaluation of oxidative stress
The area of interstitial ﬁbrosis in the marginal area of the infarct
was measured, as described previously (12). In brief, 4-mm-thick
sections were cut and stained with hematoxylin-eosin stain.
At 3 days after MI induction, the serum levels of derivatives of
reactive-oxygen metabolites (d-ROMs) were measured by the Free
Radical Elective Evaluator (Diacron International, Grosseto, Italy)
using commercial assay kits (Diacron International) (12). On
the same day, cardiac oxidative stress was assessed by
8-hydroxydeoxyguanosine (8-OHdG) content, a marker of oxida-
tive DNA damage, as described previously (15). Brieﬂy, DNA from
the LV tissues was extracted by NaI method using a DNA Extractor
TIS Kit (Wako Pure Chemical Industries, Osaka, Japan). After 50 mg
of DNA pellet was pretreated using 8-OHdG Assay Preparation
Reagent Set (Wako Pure Chemical Industries), the 8-OHdG adducts
were determined by use of an highly sensitive 8-OHdG enzyme-
linked immunosorbent assay kit (Japan Institute for the Control of
Aging, Shizuoka, Japan).
2.5. mRNA expression analysis
Total RNA in the marginal area of the infarct was extracted from
tissues or exosomes with Isogen I (Nippon Gene, Toyama) (11,16).
The concentration and quality of the RNA were assessed using a
Nano Drop 2000 spectrophotometer (Thermo, Waltham, MA, USA).
To quantify the gene expression levels, we used quantitative real-
time reverse transcription polymerase chain reaction (RT-PCR)
with the TaqMan system (Applied Biosystems, CA, USA), as previ-
ously described. For normalization, the transcript levels were
compared to those of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH).
2.6. Western blot analysis
Our detailed method has been described previously (10,12).
Protein extracts were obtained from homogenized left ventricles
with no treatment or CO2 mist treatment for 7 days. After elec-
trophoretic transfer to polyvinylidene diﬂuoride membranes
(Immobilon-P, Millipore, Billerica, MA, USA), the membranes were
probed with each primary antibody. Antibodies were obtained
from the following sources: anti-GAPDH and heat shock protein 72
(Hsp72) antibodies from Santa Cruz Biotechnology (Dallas, TX,
USA); anti-phospho endothelial nitric oxide synthase (eNOS) (p-
Ser1177), anti-phospho Akt and Akt antibodies from Cell Signaling
Technology (Beverly, MA, USA); anti-eNOS antibody from BD Bio-
sciences (San Jose, CA, USA).
2.7. Statistical analysis
All data are presented as mean ± standard error of the mean.
Differences among groups were compared by one-way analysis of
variance followed by the TukeyeKramer method, using StatView
software (SAS Institute, Inc., Cary, NC, USA). Student's t test was
used to assess differences between two groups when appropriate.
The differences were considered statistically signiﬁcant at a value of
p < 0.05.
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Fig. 1. Pretreatment with CO2 mist but not CO2 gas limits the infarct size after
myocardial infarction (MI). The hearts were stained with the Evans blue 48 h after MI
induction. (A) Representative images are shown. Red circles indicate the infarct area in
each case. (B) The infarct size was estimated in each group. All values are
mean ± standard error of the mean (SEM) (n ¼ 17e18). #p < 0.05 vs. UT. UT, MI rats
without pretreatment; CG, MI rats pretreated with CO2 gas; CM, MI rats pretreated
with CO2 mist.
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ROMs) as a marker of the systemic oxidative stress, and (F) myocardial 8-hydroxydeoxyguan
after MI induction. All values are mean ± SEM (n ¼ 8 for control group; n ¼ 11 to 14 for M
abbreviations as in Fig. 1.
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3.1. CO2 mist treatment attenuates infarct size
To demonstrate the biological functions of CO2 mist in hearts,
we ﬁrst examined the effects of CO2 gas or CO2 mist on the infarct
size in rat hearts (Fig. 1). Pretreatment with CO2 mist signiﬁcantly
reduced the infarct size at 48 h after the MI induction, compared
with no treatment. In contrast, pretreatment with only CO2 gas did
not affect the infarct size.3.2. Effects of CO2 mist pretreatment on body weight, hemodynamic
status, heart weight and oxidative stress
At 3 days after MI induction, there were no signiﬁcant differ-
ences among the groups in blood pressure and heart rate (Fig. 2A
and B). Thus, pretreatment with CO2 gas or CO2 mist had no in-
ﬂuence on the hemodynamic status. Nor was there any signiﬁcant
difference in body weight among the groups (Fig. 2C). At the same
time point, the ratio of ventricular weight to body weight, which
was increased by MI induction, did not differ between the CM
group and the UT group (Fig. 2D).
Oxidative stress is known to involve remodeling of organs or
tissue (12,17). MI-induced elevation of d-ROMs may contribute to a
worsening of cardiac remodeling. Therefore, we measured the
serum level of d-ROMs as the systemic oxidative stress, and the
myocardial 8-OHdG content as the local oxidative stress. Pretreat-
ment with CO2 mist reduced the elevation of serum d-ROM levels
(Fig. 2E). In contrast, pretreatment with CO2 gas failed to reduce it.
LV 8-OHdG content was signiﬁcantly elevated by MI induction.
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T. Yamaguchi et al. / Journal of Pharmacological Sciences 127 (2015) 474e480 477Pretreatmentwith CO2mist signiﬁcantly attenuated themyocardial
8-OHdG content after MI (Fig. 2F). Pretreatment with CO2 gas also
attenuated it, although its effect tended to be weaker than pre-
treatment of CO2 mist.
3.3. Effect of CO2 mist on gene expressions in the marginal area of
the infarction
The mRNA expressions in the LV marginal area in each group of
rats were measured by quantitative real-time RT-PCR, 3 days after
MI induction. The MI-induced increase in mRNA expressions of
monocyte chemoattractant protein-1 (MCP-1), tumor necrosis
factor (TNF)-a, and matrix metalloproteinase-9 (MMP-9), factors
closely related to cardiac inﬂammation, was signiﬁcantly lower in
the CM group but not in the CG group (Fig. 3A, B, and C).
The mRNA expressions of the collagens type I and III (Col-I and
Col-III), and transforming growth factor-b1 (TGF-b1), which are
factors closely associated with cardiac ﬁbrosis, were remarkably
increased byMI induction (Fig. 3D, E, and F). There was signiﬁcantly
less upregulation of Col-I and TGF-b1 in the CM group. Pretreat-
ment with CO2 gas also decreased MI-induced TGF-b1 expression.
Gene expressions of atrial natriuretic peptide and brain natriuretic
peptides in the marginal area were similar among the groups (data
not shown).
3.4. CO2 mist pretreatment prevents deterioration of LV function
Light micrographs of a cross-section of the mid-portion of the
left ventricle at 7 days after MI induction (Fig. 4A) revealed that the0
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Fig. 3. mRNA expressions in the left ventricular marginal area in each group 3 days after M
attractant protein-1 (MCP-1), (B) tumor necrosis factor (TNF)-a, and (C) matrix metalloprote
CM group but not in the CG group. MI increased the mRNA expressions of the (D) collagen typ
which are ﬁbrosis-related genes. There was signiﬁcantly less upregulation of Col-I and TGF-b
MI groups). *p < 0.05 vs. CON, #p < 0.05 vs. UT. Abbreviations as in Figs. 1 and 2.LV size was smaller in the CM group than in the UT group. Although
body weights in the MI groups were similar, the infarct size and
ventricular weight were signiﬁcantly lower in the CM group than in
the UT group (Fig. 4B, C and D).
On echocardiographic evaluation 7 days after MI induction, LV
end-systolic dimension, LVEDV, and LDESV were signiﬁcantly
smaller, whereas LVEF was signiﬁcantly greater in the CM group
compared with the UT group (Fig. 4E and Table 1). There was no
difference in diastolic function, including E/A, among the groups.
3.5. Effect of CO2 mist on protein levels in the left ventricle
In order to elucidate the mechanism of the effect of CO2 mist in
this model, certain protein levels were examined by western blot
analysis (Fig. 5). Interestingly, treatment with CO2 mist for 7 days
increased the phosphorylated eNOS and Akt levels in the rat left
ventricle, compared with those of untreated rats. Furthermore, the
Hsp72 level in the left ventricle of the CO2 mist-treated rats was
also signiﬁcantly elevated, compared with that of untreated rats.
4. Discussion
Themajor ﬁnding of the present study is that pretreatment with
CO2 mist reduced cardiac injury in rat hearts. Furthermore, we
provided the ﬁrst evidence that CO2 mist treatment increases the
level of LV eNOS and Akt phosphorylations and Hsp72 in this
model. As a result, CO2 mist treatment can reduce the infarct size.
Natural springs have been used as spa therapy in European
countries for many years in order to treat a variety of diseases. It is0
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T. Yamaguchi et al. / Journal of Pharmacological Sciences 127 (2015) 474e480478known that CO2-enriched water induces peripheral vasodilatation,
which increases cutaneous blood ﬂow (6e8). A recent study
demonstrated that the immersion of a unilateral ischemic hind
limb in CO2-enriched water causes an NO-dependent increase in
collateral blood perfusion in mice (18). Furthermore, we have
recently demonstrated that CO2 mist produced by a simple device,
rather than a CO2 bath, could improve the development of cardiac
remodeling after MI and accelerate angiogenesis in a mouse model
of peripheral arterial disease (9,10). However, it was still unclear
whether pretreatment with CO2 mist could protect cardiomyocytes
against ischemic injury. Our present data suggest that pretreatment
with CO2 mist, like remote ischemic preconditioning, has a car-
dioprotective effect in ischemic heart diseases (3,4).
Oxidative stress is another important factor that inﬂuences
cardiac remodeling (17). The serum level of d-ROMs was increased
byMI. Interestingly, pretreatment with CO2 mist led to signiﬁcantly
lower d-ROM levels (Fig. 2E). Furthermore, pretreatment with CO2
mist signiﬁcantly attenuated MI-induced LV 8-OHdG content
(Fig. 2F), indicating that this therapy could decrease both systemic
and local oxidative stresses via probably the compensatory actions
of some antioxidative systems, resulting in a reduction of the
accumulation of inﬂammatory cells. However, the precise mecha-
nism behind these results is still unclear.
The mRNA expression of MCP-1, TNF-a and MMP-9, which are
inﬂammatory markers, was suppressed in the marginal area of the
MI rats that were pretreated with CO2 mist. Moreover, pretreat-
ment with CO2 mist suppressed the mRNA expression of Col-I and
TGF-b1, which are markers of ﬁbrosis. TGF-b1, in particular, is apleiotropic cytokine that has been implicated as a major contrib-
utor to tissue ﬁbrosis in various organ systems. Previous studies
have shown that the expression of TGF-b1mRNA is increased in the
LV myocardium of patients with idiopathic hypertrophic cardio-
myopathy or dilated cardiomyopathy, and in animal models of
hypertension, myocardial infarction, and pressure overload (19,20).
Thus, TGF-b1 may be responsible for the development of LV
remodeling, and blocking of TGF-b1 pathways might be a phar-
macological target for the prevention of cardiac remodeling. The
results of this study suggest that the attenuation of these expres-
sions by pretreatment with CO2 mist might salvage the ischemic
myocardium and prevent increased LV enlargement in MI model
rats.
A previous study has demonstrated the possible mechanisms of
ischemic preconditioning by proteomic analysis using animal
models, but it is still unclear which were the key proteins (21). To
further investigate the mechanisms of the effect of CO2 mist, we
ﬁnally compared the LV protein levels in rats treated with CO2 for 7
days with those of untreated rats. NO is known to be a key vaso-
dilatory molecule that not only regulates vascular tone, but also has
antiplatelet, anti-inﬂammatory, and antioxidant properties (22).
NO production is also closely associated with the activation of
eNOS, which has been used as an index of vascular endothelial cell
function (23). A lack of eNOS has been implicated in accelerated
vascular remodeling with high-ﬂow stress (24). The eNOS-
dependent NO production promotes angiogenesis and suppresses
cardiac ﬁbrosis in the repair process of pressure-overloaded cardiac
dysfunction (25,26). Interestingly, treatment with CO2 mist
Table 1
Echocardiographic ﬁndings.
4 weeks after MI
CON UT CG CM
LVDd (mm) 7.25 ± 0.24 9.39 ± 0.36* 9.14 ± 0.33 8.64 ± 0.31
LVDs (mm) 4.60 ± 0.24 8.07 ± 0.22* 7.34 ± 0.36 6.57 ± 0.22#
FS (%) 36.7 ± 1.5 13.7 ± 2.0* 19.8 ± 1.9 23.7 ± 2.3#
EDV (mL) 312 ± 5 660 ± 31* 631 ± 34 493 ± 17#
ESV (mL) 115 ± 2 429 ± 13* 390 ± 33 253 ± 15#
EF (%) 63.2 ± 0.5 34.6 ± 2.0* 39.0 ± 3.0 48.8 ± 1.8#
E (cm/s) 62.2 ± 1.8 72.7 ± 4.7 71.2 ± 5.8 64.9 ± 5.4
A (cm/s) 43.7 ± 1.9 37.8 ± 2.1 46.2 ± 4.3 34.8 ± 2.7
E/A 1.43 ± 0.05 1.95 ± 0.15 1.63 ± 0.18 1.96 ± 0.25
LVDd; left ventricular end-diastolic diameter, LVDs; left ventricular end-systolic
diameter, FS; fractional shortening, ESV; left ventricular end-systolic volume,
EDV; left ventricular end-diastolic volume, EF; ejection fraction. E; early rapid ﬁlling
wave of mitral inﬂow velocities, A; atrial contraction wave of mitral inﬂow veloc-
ities, E/A; the ratio of E wave velocity to A wave velocity. All data are presented as
mean ± SEM.
*p < 0.05 vs CON, #p < 0.05 vs UT.
T. Yamaguchi et al. / Journal of Pharmacological Sciences 127 (2015) 474e480 479increased its activation, suggesting that increased eNOS activity
may result in improved LV function in this model.
Hsps are expressed in both prokaryotes and eukaryotes, and are
generally highly conserved. Hsp72, which is the most prominent
member of the Hsp70 family, is located within both the cytoplasm
and the nucleus. Numerous studies have shown that Hsp72 con-
tributes to the prevention of protein aggregation, assists in
refolding damaged proteins, chaperones nascent polypeptides
along ribosomes, aids in the removal of damaged proteins, and is
involved in protecting cells against a variety of stresses (27e29).p-eNOS
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Akt and Hsp72 is shown. Mean values in the control group are represented as 1. All valuesNotably, recent studies have reported that moderate exercise,
combinedwith certain agents, can exert a cardioprotective effect by
increasing Hsp72 protein levels in the heart and liver (30, 31). In the
present study, treatment with CO2 mist signiﬁcantly increased
Hsp72 protein levels in the left ventricles of rats. Thus, increased
Hsp72 protein levels may be a topic of great interest in the dis-
cussion as to how best to prevent MI-induced LV dysfunction.
However, the mechanistic relation between CO2 mist and LV Hsp72
levels remains unclear. Further studies are needed to adequately
explore the precise mechanisms underlying the effect of CO2 mist
on LV function.4.1. Study limitation
Our previous study have shown that there was no effect of
arterial and venous blood gases with CO2 mist and CO2 gas treat-
ment under either chronic or acute conditions (9). In contrast, the
tissue saturation levels were signiﬁcantly increased in the CO2 mist
treatment group compared with the CO2 gas treatment group,
suggesting that CO2 mist had increased blood ﬂow effects
compared with CO2 gas alone. It could result in shortened blood
capillary transit time, which would cause a reduction in the
extraction of oxygen from the blood and release oxygen more
easily. However, the observations in the present study do not show
the precise mechanism of cardioprotective effects of CO2 mist. It is
also unclear whether repetitive treatment of CO2 mist has an effect
on other organs such as blood vessels and kidney. Therefore, further
studies are needed to elucidate the precise mechanism of the ef-
fects of CO2 mist before clinical applications.CM
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st. (A) Representative western blot analysis of phosphorylated endothelial nitric oxide
osphate dehydrogenase (GAPDH) levels in each group. (B) Quantiﬁcation of p-eNOS, p-
are mean ± SEM (n ¼ 6e7). #p < 0.05 vs. UT.
T. Yamaguchi et al. / Journal of Pharmacological Sciences 127 (2015) 474e480480In conclusion, we have demonstrated that pretreatment with
CO2mistmay have an ischemic preconditioning effect by increasing
eNOS activation and Hsp72 levels while suppressing oxidative
stress, resulting in the attenuation of infarct size. CO2 mist pre-
parative treatment might be potentially useful for preserving
myocardium in ischemic heart diseases.
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